Verona Pharma PLC Director Dealing (7030G)

TIDMVRP

RNS Number : 7030G

Verona Pharma PLC

09 August 2016

Verona Pharma plc

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Dr. Jan-Anders Karlsson 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                Chief Executive Officer 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Verona Pharma plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      n/a 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of         Ordinary Shares of 0.1 pence each 
       instrument                                                GB00B06GSH43 
       Identification code 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Jan-Anders Karlsson purchased 600,000 Ordinary Shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                      Price(s)      Volume(s) 
                                                                 --------------  ---------- 
                                                                  3.249 pence     600,000 
                                                                   per Ordinary    Ordinary 
                                                                   Share           Shares 
                                                                 --------------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                   600,000 Ordinary Shares at 3.249 pence per Ordinary 
        - Aggregated volume                                     Share 
        - Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
 e)    Date of the transaction                                  9 August 2016 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 London Stock Exchange, AIM 
----  -------------------------------------------------------  -------------------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSSLFDUFMSEFA

(END) Dow Jones Newswires

August 09, 2016 09:16 ET (13:16 GMT)

Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024